CIT can broadcast your seminar, conference or meeting live to a world-wide
audience over the Internet as a real-time streaming video. The event can
be recorded and made available for viewers to watch at their convenience
as an on-demand video or a downloadable podcast. CIT can also broadcast
NIH-only or HHS-only content.
The National Institutes of Health and the Food and Drug Administration are collaborating on a series of workshops on moving pluripotent stem cell therapies into the clinic.
The first two day workshop, “Pluripotent Cells in Translation: Early Decisions,” is scheduled for March 21 and 22 at Lister Hill Auditorium on the NIH campus in Bethesda, Maryland. The first day will cover pluripotency and its challenges, sources of pluripotent cells, and stem cell banks; the second day will cover making pluripotent stem cells into a product, product characterization, and emerging technologies.
The meeting has participation from industry, academic and clinical scientists, the FDA, and the NIH.
Pluripotent stem cells in translation : early decisions [electronic resource] / NIH and FDA.
Author:
National Institutes of Health (U.S.)
Publisher:
[Bethesda, Md. : National Institutes of Health, 2011]
Abstract:
(CIT): The National Institutes of Health and the Food and Drug Administration are collaborating on a series of workshops on moving pluripotent stem cell therapies into the clinic. The first two day workshop, "Pluripotent Cells in Translation: Early Decisions," is scheduled for March 21 and 22 at Lister Hill Auditorium on the NIH campus in Bethesda, Maryland. The first day will cover pluripotency and its challenges, sources of pluripotent cells, and stem cell banks; the second day will cover making pluripotent stem cells into a product, product characterization, and emerging technologies. The meeting has participation from industry, academic and clinical scientists, the FDA, and the NIH.
